1OFX image
Deposition Date 1991-10-17
Release Date 1993-04-15
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1OFX
Keywords:
Title:
CRYSTAL STRUCTURE OF AN OKAZAKI FRAGMENT AT 2 ANGSTROMS RESOLUTION
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Observed:
0.15
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*GP*GP*GP*TP*AP*TP*AP*CP*GP*C)-3')
Chain IDs:A
Chain Length:10
Number of Molecules:1
Biological Source:
Polymer Type:polydeoxyribonucleotide/polyribonucleotide hybrid
Molecule:DNA/RNA (5'-R(*GP*CP*GP*)-D(*TP*AP*TP*AP*CP*CP*C)-3')
Chain IDs:B
Chain Length:10
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
Crystal structure of an Okazaki fragment at 2-A resolution.
Proc.Natl.Acad.Sci.USA 89 534 538 (1992)
PMID: 1370582 DOI: 10.1073/pnas.89.2.534

Abstact

In DNA replication, Okazaki fragments are formed as double-stranded intermediates during synthesis of the lagging strand. They are composed of the growing DNA strand primed by RNA and the template strand. The DNA oligonucleotide d(GGGTATACGC) and the chimeric RNA-DNA oligonucleotide r(GCG)d(TATACCC) were combined to form a synthetic Okazaki fragment and its three-dimensional structure was determined by x-ray crystallography. The fragment adopts an overall A-type conformation with 11 residues per turn. Although the base-pair geometry, particularly in the central TATA part, is distorted, there is no evidence for a transition from the A- to the B-type conformation at the junction between RNA.DNA hybrid and DNA duplex. The RNA trimer may, therefore, lock the complete fragment in an A-type conformation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures